Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|January 22, 2011
Potent and selective cyclohexyl-derived imidazopyrazine insulin-like growth factor 1 receptor inhibitors with in vivo efficacyMeizhong Jin, Andrew Kleinberg, Andy Cooke, et al.
Organic & Biomolecular Chemistry|December 14, 2006
A highly effective one-pot synthesis of quinolines from o-nitroarylcarbaldehydesAn-Hu Li, Eilaf Ahmed, Xin Chen, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2006
1,3-Disubstituted-imidazo[1,5-a]pyrazines as insulin-like growth-factor-I receptor (IGF-IR) inhibitorsMark J Mulvihill, Qun-Sheng Ji, Doug Werner, et al.
Molecular Cancer Therapeutics|September 4, 2025
In Vivo Tumor Growth Control by General Control Nonderepressible 2-Targeting Agents Results from Kinase ActivationFeven Tameire, Paulina Wojnarowicz, Crissy Dudgeon, et al.
Molecular Cancer Therapeutics|August 20, 2025
In Vivo Tumor Growth Control by General Control Nonderepressible 2 Targeting Agents Results from Kinase ActivationFeven Tameire, Paulina Wojnarowicz, Crissy Dudgeon, et al.
The Journal of Organic Chemistry|August 3, 2012
Synthesis and profiling of a diverse collection of azetidine-based scaffolds for the development of CNS-focused lead-like librariesJason T Lowe, Maurice D Lee, Lakshmi B Akella, et al.
Organic Letters|November 8, 2014
Total synthesis of 6-deoxypladienolide D and Assessment of Splicing Inhibitory Activity in a Mutant SF3B1 cancer cell lineKenzo Arai, Silvia Buonamici, Betty Chan, et al.
Journal of the American Chemical Society|November 12, 2010
An aldol-based build/couple/pair strategy for the synthesis of medium- and large-sized rings: discovery of macrocyclic histone deacetylase inhibitorsLisa A Marcaurelle, Eamon Comer, Sivaraman Dandapani, et al.
Bioorganic & Medicinal Chemistry|November 7, 2007
Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitorsMark J Mulvihill, Qun-Sheng Ji, Heather R Coate, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2006
3-[6-(2-Dimethylamino-1-imidazol-1-yl-butyl)-naphthalen-2-yloxy]-2,2-dimethyl-propionic acid as a highly potent and selective retinoic acid metabolic blocking agentMark J Mulvihill, Julie L C Kan, Andrew Cooke, et al.
Pageof 7